Michael P. Cooke, Chief Scientific Officer at Magenta Therapeutics, Inc. (MGTA), sold 7,500 shares at $13.31 ($98K) on 2019-12-02, disclosed to the SEC on 2019-12-02.
Open-market sale of $98k MGTA by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.74 | 3,627 | $46K | 47.4% |
| 2 | $13.21 | 2,500 | $33K | 33.9% |
| 3 | $13.31 | 1,373 | $18K | 18.7% |
| Total | $13.00 avg | 7,500 | $98K | 100% |
| Filing → |
| MGTA | SELL | 2019-10-03 | $50K | — | Filing → |
| MGTA | SELL | 2019-09-19 | $20K | — | Filing → |
| MGTA | SELL | 2019-09-16 | $10K | — | Filing → |